The use of bevacizumab is correlated with improved post-progression survival in advanced recurrent ovarian cancer.
Sign Up to like & getrecommendations! Published in 2021 at "Japanese journal of clinical oncology"
DOI: 10.1093/jjco/hyab105
Abstract: BACKGROUND The recent improvements in anti-cancer therapy following first-line treatment can potentially impact post-progression survival. We evaluated the factors that influence post-progression survival in advanced recurrent ovarian cancer. METHODS Eighty-nine patients who underwent first-line treatment… read more here.
Keywords: bevacizumab; post progression; progression survival; progression ... See more keywords
Survival after failure of first-line chemotherapy in advanced gastric cancer patients: differences between Japan and the rest of the world
Sign Up to like & getrecommendations! Published in 2017 at "Japanese Journal of Clinical Oncology"
DOI: 10.1093/jjco/hyx044
Abstract: In this review, we focus on post-progression survival after first-line chemotherapy of advanced gastric cancer, and particularly the differences between Japan and the rest of the world. We reviewed 15 recent phase III trials of… read more here.
Keywords: post progression; survival; rest world;
Abstract 2468: Phase II study of cryoablation and post-progression immune checkpoint inhibition in metastatic melanoma
Sign Up to like & getrecommendations! Published in 2024 at "Cancer Research"
DOI: 10.1158/1538-7445.am2024-2468
Abstract: Introduction: Efforts to overcome resistance to immune checkpoint inhibition (ICI) are paramount, and novel combination strategies are in development. Image-guided percutaneous cryoablation is an established minimally invasive oncologic treatment that has demonstrated immune modulatory effects.… read more here.
Keywords: post progression; cryoablation; post; tumor ... See more keywords
Analysis of Post-Progression Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib
Sign Up to like & getrecommendations! Published in 2020 at "Oncology"
DOI: 10.1159/000509387
Abstract: Background: Although a strong antitumor effect of lenvatinib (LEN) has been noted for patients with unresectable hepatocellular carcinoma (HCC), there are still no reports on the prognosis for patients with disease progression after first-line LEN… read more here.
Keywords: post progression; line; first line; line len ... See more keywords
Post-progression survival of patients with metastatic hormone-sensitive prostate cancer (mHSPC) who received darolutamide or placebo: Post hoc analysis of ARASENS.
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2024.42.16_suppl.5083
Abstract: 5083 Background: Darolutamide (DARO) is a structurally distinct and highly potent androgen receptor pathway inhibitor (ARPI). In ARASENS (NCT02799602), the addition of DARO to androgen-deprivation therapy (ADT) and docetaxel (DOC) significantly reduced the risk of… read more here.
Keywords: post progression; survival; progression; daro ... See more keywords
Disease management costs and healthcare resource utilization by progression health state among patients with previously untreated locally advanced or metastatic urothelial cancer.
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2025.43.5_suppl.714
Abstract: 714 Background: Significant disease management cost (DMC) burden and healthcare resource utilization (HRU) have been reported for patients with advanced bladder cancer; however, available data were outdated. We estimated the real-world DMC and HRU for… read more here.
Keywords: post progression; progression health; treatment; progression ... See more keywords
Impact of Post-progression Survival on Outcomes of Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma: A Systematic Review and Retrospective Cohort Study
Sign Up to like & getrecommendations! Published in 2022 at "AntiCancer Research"
DOI: 10.21873/anticanres.16112
Abstract: Background/Aim: Lenvatinib is a tyrosine kinase inhibitor (TKI) more effective against hepatocellular carcinoma (HCC) than sorafenib, making lenvatinib a first-line treatment option for patients with unresectable HCC. In patients treated with sorafenib, post-progression survival (PPS)… read more here.
Keywords: hepatocellular carcinoma; survival; post progression; line ... See more keywords
Progression Patterns and Post-Progression Survival in Recurred Intrahepatic Cholangiocarcinoma Patients: A Novel Prognostic Nomogram Based on Multicenter Cohorts
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.832038
Abstract: Background The post-progression survival (PPS) of recurred intrahepatic cholangiocarcinoma (iCCA) patients relates to the characteristics of tumor progression. Moreover, the prediction model of PPS in those patients has not been well established. This study aimed… read more here.
Keywords: pps; progression survival; progression; post progression ... See more keywords
A Nomogram Model to Predict Post-Progression Survival in Esophageal Squamous Cell Carcinoma Patients With Recurrence After Radical Resection
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.925685
Abstract: Background Esophageal squamous cell carcinoma (ESCC) is characterized clinically by frequent recurrence, leading to a poor prognosis after radical surgery. The aim of this study was to identify a prognostic nomogram to predict the post-progression… read more here.
Keywords: cell carcinoma; squamous cell; post progression; recurrence ... See more keywords
Real-World Analysis of Post-Progression Treatment Patterns and Outcomes for EGFR Mutation-Positive Patients Treated with First-Line Osimertinib
Sign Up to like & getrecommendations! Published in 2024 at "Current Oncology"
DOI: 10.3390/curroncol31050182
Abstract: Introduction: The use of osimertinib in the first-line (1L) setting is an effective treatment option for sensitizing EGFR-mutations (EGFRm+) and has significantly altered the standard of care practice for EGFRm+ disease in Canada. Unfortunately, acquired… read more here.
Keywords: post progression; treatment; progression; real world ... See more keywords